FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagede.medizininformatikinitiative.kerndatensatz.onkologie
Resource TypeCarePlan
IdCarePlan-mii-exa-onko-tumorkonferenz-pure-molecular.json
FHIR VersionR4

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source


English


Generated Narrative: CarePlan mii-exa-onko-tumorkonferenz-pure-molecular

Profile: MII PR Onkologie Tumorkonferenz version: 2027.0.0-ballot.1

identifier: Tumorkonferenz_Molecular_002

status: Active

intent: Plan

category: Molekulares Tumorboard - Precision Medicine

subject: Maria Müller Female, DoB: 1968-07-22 ( https://www.medizininformatik-initiative.de/fhir/sid/patienten#MTB-2024-001)

created: 2024-01-16

addresses: Condition Bösartige Neubildung: Brustdrüse, nicht näher bezeichnet

activity

progress:

HER2+ with T790M mutation and brain metastases - specific agent sequence based on resistance profile

reference: RequestGroup zielgerichtete Substanzen

activity

progress:

Neurosurgical consultation recommended for brain metastases management

reference: ServiceRequest Consultation


German


Generated Narrative: CarePlan mii-exa-onko-tumorkonferenz-pure-molecular

Profile: MII PR Onkologie Tumorkonferenz version: 2027.0.0-ballot.1

identifier: Tumorkonferenz_Molecular_002

status: Active

intent: Plan

category: Molekulares Tumorboard - Precision Medicine

subject: Maria Müller Female, DoB: 1968-07-22 ( https://www.medizininformatik-initiative.de/fhir/sid/patienten#MTB-2024-001)

created: 2024-01-16

addresses: Condition Bösartige Neubildung: Brustdrüse, nicht näher bezeichnet

activity

progress:

HER2+ with T790M mutation and brain metastases - specific agent sequence based on resistance profile

reference: RequestGroup zielgerichtete Substanzen

activity

progress:

Neurosurgical consultation recommended for brain metastases management

reference: ServiceRequest Consultation


Source1

{
  "resourceType": "CarePlan",
  "id": "mii-exa-onko-tumorkonferenz-pure-molecular",
  "meta": {
    "profile": [
      "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-tumorkonferenz|2027.0.0-ballot.1"
    ]
  },
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "identifier": [
    {
      "value": "Tumorkonferenz_Molecular_002"
    }
  ],
  "status": "active",
  "intent": "plan",
  "category": [
    {
      "coding": [
        {
          "system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapieplanung-typ",
          "code": "praeth"
        }
      ],
      "text": "Molekulares Tumorboard - Precision Medicine"
    }
  ],
  "subject": {
    "reference": "Patient/mii-exa-onko-molecular-board-patient"
  },
  "created": "2024-01-16",
  "addresses": [
    {
      "reference": "Condition/primaertumor-example"
    }
  ],
  "activity": [
    {
      "progress": [
        {
          "text": "HER2+ with T790M mutation and brain metastases - specific agent sequence based on resistance profile"
        }
      ],
      "reference": {
        "reference": "RequestGroup/mii-exa-onko-molecular-her2-alternatives"
      }
    },
    {
      "progress": [
        {
          "text": "Neurosurgical consultation recommended for brain metastases management"
        }
      ],
      "reference": {
        "reference": "ServiceRequest/mii-exa-onko-molecular-surgery-request"
      }
    }
  ]
}